Literature DB >> 15578589

Behavioral aspects of Angelman syndrome: a case control study.

Raymond J Barry1, Raymond J Berry, Robert P Leitner, Adam R Clarke, Stuart L Einfeld.   

Abstract

Angelman syndrome (AS) is a rare congenital disorder characterized by impairments in intellectual, neurological and motor functioning and a postulated behavioral profile. This study compared behavioral characteristics of 62 individuals with genetically confirmed AS and 29 individuals with presumed AS from clinical features, with a control group of young persons with intellectual disability (ID) derived from an Australian epidemiological register. Twelve behavioral items from the developmental behavior checklist (DBC) were used for this comparison. The groups were matched for chronological age, gender, and level of ID. In the AS group, significant differences were found for 10 behaviors, with poor attention span and impulsivity being less common, and overactivity/restlessness, chewing or mouthing objects, eating non-food items, gorging food, food fads, fascination for water, hand flapping and sleep disturbance being more common. Interestingly, there was no difference in prevalence of unprovoked laughter. Comparison of the results of the genetically confirmed with the genetically unconfirmed AS cases showed no significant differences between individual behavior prevalence. These findings show that a "behavioral phenotype" of AS can be distinguished from others of similar level of ID, but it is different from that hitherto published. Abnormal food related behaviors, hyperactivity, fascination for water, hand flapping, and sleep disturbance should be included in a "behavioral phenotype" for AS. Apart from hyperactivity, "ADHD-type" behaviors are not more characteristic of AS than in ID generally. Therefore, the Consensus Criteria for the diagnosis of AS need to be reviewed. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15578589     DOI: 10.1002/ajmg.a.30154

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  Sleep in children and adolescents with Angelman syndrome: association with parent sleep and stress.

Authors:  S E Goldman; T J Bichell; K Surdyka; B A Malow
Journal:  J Intellect Disabil Res       Date:  2011-11-02

2.  Angelman syndrome: Mutations influence features in early childhood.

Authors:  Wen-Hann Tan; Carlos A Bacino; Steven A Skinner; Irina Anselm; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Jennifer K Gentile; Daniel G Glaze; Lucia T Horowitz; Sanjeev V Kothare; Hye-Seung Lee; Mark P Nespeca; Sarika U Peters; Trilochan Sahoo; Dean Sarco; Susan E Waisbren; Lynne M Bird
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

3.  Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.

Authors:  Jiandong Sun; Yan Liu; Stephanie Moreno; Michel Baudry; Xiaoning Bi
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

4.  mTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice.

Authors:  Jiandong Sun; Yan Liu; Jennifer Tran; Patrick O'Neal; Michel Baudry; Xiaoning Bi
Journal:  Cell Mol Life Sci       Date:  2016-05-12       Impact factor: 9.261

5.  Brief Report: Challenging Behaviors in Toddlers and Preschoolers with Angelman, Prader-Willi, and Williams Syndromes.

Authors:  Wei Siong Neo; Bridgette L Tonnsen
Journal:  J Autism Dev Disord       Date:  2019-04

6.  The ghost in our genes: legal and ethical implications of epigenetics.

Authors:  Mark A Rothstein; Yu Cai; Gary E Marchant
Journal:  Health Matrix Clevel       Date:  2009

7.  Misleading behavioural phenotype with adenylosuccinate lyase deficiency.

Authors:  Cyril Gitiaux; Irène Ceballos-Picot; Sandrine Marie; Vassili Valayannopoulos; Marlène Rio; Séverine Verrieres; Jean François Benoist; Marie Françoise Vincent; Isabelle Desguerre; Nadia Bahi-Buisson
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

Review 8.  Potential therapeutic approaches for Angelman syndrome.

Authors:  Xiaoning Bi; Jiandong Sun; Angela X Ji; Michel Baudry
Journal:  Expert Opin Ther Targets       Date:  2015-11-26       Impact factor: 6.902

9.  Evaluation of autism traits in Angelman syndrome: a resource to unfold autism genes.

Authors:  Maria Teresa Bonati; Silvia Russo; Palma Finelli; Maria Rosa Valsecchi; Francesca Cogliati; Florinda Cavalleri; Wendy Roberts; Maurizio Elia; Lidia Larizza
Journal:  Neurogenetics       Date:  2007-04-06       Impact factor: 3.017

10.  CIM6P/IGF-2 Receptor Ligands Reverse Deficits in Angelman Syndrome Model Mice.

Authors:  Emmanuel Cruz; Giannina Descalzi; Adam Steinmetz; Helen E Scharfman; Aaron Katzman; Cristina M Alberini
Journal:  Autism Res       Date:  2020-10-27       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.